Trial intelligence / Profile preview

Banxia Baizhu Tianma decoction for borderline hypertension

ChiCTR2000035796Phase 3Not yet recruiting

Sponsor
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Start
Oct 2020
Countries
1
01

Overview

Phase 3, randomised trial of Ban Xia Bai Zhu Tian Ma Tang in prehypertension (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoint: ratio of blood pressure improvement. Planned start Oct 2020; status: not yet recruiting.

02

Drugs

Ban Xia Bai Zhu Tian Ma Tang
03

Conditions

prehypertension

Beyond the preview

Go deeper on ChiCTR2000035796.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000035796.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call